Earnings ·
LENSAR reports Q3 revenue of $14.1M, recurring revenue up 17% to $12.6M
LNSRLENSAR, Inc.
LENSAR reported third-quarter 2026 total revenue of $14.1 million, a 1% decline year-over-year driven by lower system sales against a strong prior-year base. Recurring revenue grew 17% to $12.6 million, representing 89% of total revenue, while procedure volume increased 12% to 52,545. The company placed 10 ALLY robotic cataract laser systems during the quarter, bringing the installed base to approximately 225 units and a total backlog of 12 systems as of September 30. Adjusted EBITDA turned positive at $1.7 million compared to a loss in the prior year period. LENSAR is a medical technology company focused on advanced robotic laser solutions for cataract treatment.